The assessment of cardiovascular risk is uniformly recommended as a decision-support for therapies aimed at preventing cardiovascular diseases. Our objective was to determine the prognostic significance of vascular markers in apparently healthy subjects. Analyses were based on the Third Toulouse MONICA Survey (1995)(1996)(1997) carried out in participants aged 35-64, from the general population of South-western France. Causes of death were obtained 14 years after inclusion. There were 1132 participants (51% men). Over the 14-year follow-up period, 61 deaths were recorded, 20% due to a cardiovascular cause. Adding pulse wave velocity (PWV) to Framingham Risk Score (FRS) improved the accuracy of the risk prediction model. The C-statistic increased from 0.76 (95% confidence interval (CI): 0.64-0.89) (FRS alone) to 0.79 (95% CI: 0.64-0.95) (FRS þ PWV). The Integrated Discrimination Improvement (IDI) reached 3.81% (P-valueo0.001) and the net reclassification improvement (NRI) was equal to 32%. Risk prediction was also improved by integrating pulse pressure (PP) in the model (C-statistic ¼ 0.81 (95% CI: 0.66-0.96); IDI ¼ 4.99% (P-valueo0.001); NRI ¼ 30%) or the number of carotid or femoral atherosclerotic plaques (C-statistic ¼ 0.78 (95% CI: 0.63-0.93); IDI ¼ 2.21% (P-valueo0.001); NRI ¼ 21%). Vascular markers are independent determinants of cardiovascular mortality in apparently healthy subjects and improve risk prediction.
INTRODUCTION
The assessment of cardiovascular risk is uniformly recommended as a decision-support for therapeutic management aimed at preventing cardiovascular diseases in primary prevention. The Framingham Risk Score (FRS) 1 is the formula most commonly used worldwide to assess cardiovascular risk. Subjects with an estimated 10-year probability of coronary heart disease higher than 20% are considered to be at high risk, although they are in primary prevention. Nevertheless, cardiovascular events are also encountered among subjects with an estimated risk below 20%, in particular when there is one single marked elevated risk factor. As suggested by the European Society of Cardiology 2 and the American Heart Association, 3 risk estimation could be improved by the use of additional risk markers, such as vascular markers of subclinical atherosclerosis. In first instance, carotid intima-media thickness (IMT) and carotid atherosclerotic plaques have been shown to be significant determinants of cardiovascular events, both in patients in secondary cardiovascular prevention and in asymptomatic subjects. [4] [5] [6] [7] Pulse wave velocity (PWV) has also been described as an independent predictor of cardiovascular risk in patients at high cardiovascular risk and in the general population. 8, 9 Pulse pressure (PP), a simple indirect measure of arterial stiffness (corresponding to the difference between systolic and diastolic blood pressure), predicts cardiovascular risk in hypertensive subjects, in the elderly, and in apparently healthy subjects. [10] [11] [12] However, only few studies have previously investigated the role of vascular markers in improving prediction and stratification of cardiovascular risk, in apparently healthy subjects. [13] [14] [15] [16] [17] [18] [19] The aim of this study was to determine the prognostic significance of vascular markers in apparently healthy subjects, and to assess their additional value in predicting cardiovascular death, compared with traditional cardiovascular risk factors.
MATERIALS AND METHODS

Study population and study design
A sample of 1175 subjects was recruited to participate in the Third Toulouse MONICA Survey on the prevalence of cardiovascular risk factors. [20] [21] [22] The study was approved by an institutional ethics committee in agreement with the French law on human biomedical research and the Declaration of Helsinki. Middle-aged men and women (35-64 years old) were recruited between December 1994 and July 1997. Polling lists available in each town hall of Toulouse area (South-western France) were used to obtain the stratified random sample. The stratification was applied on town size (rural versus urban), age and gender, in order to obtain 200 subjects in each 10-year age group (35-44; 45-54 and 55-64 years) and gender. No incentive to participate (in particular no financial incentive) was offered. The informed consent to participate in the study was obtained for each subject. As we aimed to study apparently healthy people in primary prevention of cardiovascular disease, subjects with the following medical histories were excluded from the analyses: clinical or subclinical ischaemic heart disease (International Classification of Disease, 9th revision, codes 410.0 to 414.9), clinical or subclinical atherosclerotic cerebrovascular disease (433.0 to 438.9, except codes 437.3 to 437.7), documented atherosclerosis in other arteries such as aorta, renal or lower limb arteries (440.0 to 440.9), chronic renal failure (585.0 to 585.9), chronic respiratory insufficiency (496.0 to 496.9), chronic heart failure (428.0 to 428.9), chronic liver disease or cirrhosis (571.0 to 571.9) and cancer, with the exception of benign neoplasms and in-situ carcinoma (140.0 to 209.9 and 235.0 to 239.9). Overall, 31 participants were excluded for the above reasons. Besides, 12 other people could not be maintained in the analyses because of missing data on determinants of FRS. Finally, the analysed sample comprised 1132 subjects.
Vital status on 31 December 2009 was obtained for each participant through the national database recording each year all deaths occurring in French people (RNIPP). 23 All dates and causes of death were obtained for participants who died during the follow-up. For each participant, the length of follow-up corresponds to the period between the inclusion date (December 1994-July 1997) and 31 December 2009, or the date of death. Principal and associated causes of death were provided by the French National Institute of Health Research (Cé piDc-INSERM), which systematically collects and codes (using the International Classification of Diseases coding system) data recorded on death certificates. Authorizations to use these data were obtained, as requested by the French law. Death from a cardiovascular cause (Ischaemic Heart Disease, Atherosclerotic Cerebrovascular Disease or Atherosclerosis) during the follow-up was assessed by a committee of four medical doctors every time cardiovascular disease was reported as the main cause of death, or when it was mentioned as an associated cause, if the main cause was a plausible complication of cardiovascular disease.
Questionnaires and measurement of clinical parameters
At baseline, extensive questionnaires were filled in by a trained and certified medical staff, during a face to face interview with the participant. Data regarding socio-economic level, personal medical history, cardiovascular risk factors, drug intake and life style habits were recorded. People who smoked regularly during the previous year were considered as smokers. Arterial blood pressure (mean of two measurements performed with a standard sphygmomanometer in a sitting position after a 5-min rest, at least) was measured according to standardised protocols by the medical staff. PP was calculated as the difference between systolic blood pressure and diastolic blood pressure.
Laboratory methods
Blood samples were taken after at least 10 h of overnight fasting. Serum total cholesterol and triglycerides were measured by enzymatic assays (Boehringer, Mannheim, Germany). High density lipoprotein cholesterol measurement was done after sodium phosphotungstatemagnesium chloride precipitation of apo B-containing lipoproteins. Low density lipoprotein cholesterol was determined by Friedewald formula, when triglycerides were below 4.6 mmol l À 1 (400 mg dl À 1 ). 24 Glucose levels were measured using a conventional enzymatic method based on hexokinase-glucose-6-phosphate dehydrogenase. Diabetes was defined as hypoglycaemic drug use or fasting blood glucoseX7.7 mmol l 
Ultrasonography
High-resolution B-mode ultrasonography was used to identify atherosclerotic plaques in carotid and femoral artery beds and to measure common carotid IMT. An ATL UM9 system (Advanced Technology Laboratories Ultramark 9 High Definition Imaging, Advanced Technology Laboratories, Bothel, WA, USA) was used with a 7.4 MHz transducer. The potential presence of atherosclerotic plaques was investigated in the right and left common carotid arteries, internal carotid arteries (including carotid bulbs) and femoral arteries (including femoral bifurcations). A plaque was defined as a distinct zone identified with either a focal area of hyperechogenicity relative to adjacent segments or a focal protrusion into the lumen of the vessel, composed of only calcified deposits or a combination of calcified and non calcified material. 25 Common carotid IMT was defined as the distance between the mediaadventitia interface and the lumen-intima interface, avoiding plaque sites. IMT measurements were performed on the right and left common carotid arteries, on the far wall exclusively. Three points at two locations (proximal and middle, with about 10-15 mm intervals, the most cranial point being about 15-20 mm from the bifurcation) were measured on each artery, giving a total of 12 points. The values at the 12 sites were combined to obtain an overall mean common carotid IMT (Eurequa, TSA Company, Meudon, France). 26 
Arterial stiffness
Arterial stiffness was assessed by PWV measurement, which is a classic index of arterial stiffness. A semiautomatic device was used to measure carotidfemoral PWV: 27 Complior (Garges les Gonesse, France). Pulse wave was recorded using a TY-306 Fukuda pressure sensitive transducer (Fukuda, Tokyo, Japan). Pressure waveforms were digitised. The sample acquisition frequency for carotid-femoral PWVwas set at 500 Hz. The two pressure waveforms were stored in a memory buffer. A preprocessing system automatically analysed gain in each waveform and adjusted it for equality of the two signals. When the quality of the pulse waveform observed on the computer screen was satisfactory, digitisation was suspended and a calculation of the time delay (t) between the two pressure upstrokes was automatically determined by the Complior. This procedure was repeated on 10 different cardiac cycles and the mean value was used in the analyses. The distance covered by the pulse wave was measured on body surface and represented the distance between the two recording sites (D). PWV was automatically calculated as PWV ¼ D/t. The validation of this automatic method has previously been described elsewhere. 27 
Statistical analysis
Statistical analysis was performed on STATA statistical software, release 11.2 (STATA Corporation, College station, TX, USA).
We first described baseline characteristics of participants. Then we compared subjects alive at the end of the follow-up, those who died from a noncardiovascular cause and those who died from a cardiovascular disease. Categorical variables were compared between groups using the w 2 -test (or Fisher's exact when necessary). One-way analysis of variance was used to compare the distribution of continuous data (or Kruskall-Wallis test when the distribution of the continuous variable departed from normality or when homoscedasticity was rejected).
To determine the prognostic significance of vascular markers, a survival analysis adjusted for FRS was conducted, using successively PWV, PP, number of carotid or femoral plaque (CFP) or IMT as explanatory variables. Events were cases of cardiovascular death. Hazard ratios for cardiovascular mortality and 95% confidence intervals (CI) were assessed using a proportional subdistribution hazard model, which is an extension of the Cox model to the situation of competing risks. 28 As the log-linearity hypothesis was not fully respected, the following continuous variables were transformed into ordered data: FRS (o 10%, 10-20%,420%), PWV (o 10 m s À 1 andX10 m s À 1 (fourth quartile)), PP (o 58 mm Hg andX58 mm Hg (fourth quartile)), number of CFP (o 2 andX2 (fourth quartile)) and IMT (o 0.65 mm andX0.65 mm (fourth quartile)). The proportional-hazard assumption was tested for each covariate by the 'log-log' plot method curves (-ln(-ln(survival))), for each category of nominal covariate, versus ln(analysis time). None of the assumptions could be rejected. The predictive value was assessed by using the likelihood ratio test. The calibration was appreciated with the w 2 -Hosmer-Lemeshow statistic, which compares the observed event risk with the average predicted risk in the different deciles of predicted risk. The C-statistic was estimated to assess discrimination. Integrated Discrimination Improvement (IDI) and net reclassification improvement (NRI) were also computed. 29, 30 For the reclassification analysis, we used standard clinical cut points to identify high cardiovascular risk subjects (420% for FRS and 45% for cardiovascular death 31 ). We cross-classified categories of risk estimated with FRS against those estimated with a model based on FRS plus a vascular marker (successively PWV, PP, number of CFP and IMT). Crossclassification was assessed separately in participants who did and in those who did not die from a cardiovascular cause. Unlike NRI, IDI is rather based on continuous than binary differences in predicted risk. Thus, it does not depend on the choice made to define risk categories.
RESULTS
Description of the population sample Table 1 describes the main characteristics of participants. Mean age was 50 years (± 8.5 years), 51% of participants were men, 27% were smokers and 6% were diabetics. Mean blood pressure Table 2 describes the main characteristics of participants according to life status at the end of the follow-up (alive, dead from a noncardiovascular cause, or dead from a cardiovascular disease). Advanced age, diabetes, high systolic blood pressure, high FRS and vascular markers (being in the fourth quartile of the distribution) were all significantly associated with cardiovascular death.
Survival analysis PWV, PP and number CFP were significant and independent determinants of cardiovascular mortality (Table 3 ). The addition of these vascular markers to FRS in risk prediction models resulted in an improvement in the C-statistic (0.76 (95% CI: 0.64-0.89) for FRS alone, 0.79 (95% CI: 0.64-0.95) for FRS and PWV, 0.81 (95% CI: 0.66-0.96) for FRS and PP, 0.78 (95% CI: 0.63-0.93) for FRS and number of CFP). The IDI indexes were 3.81, 4.99 and 2.21% (Pvalueso0.001) when PWV, PP and number of CFP were used as additional predictors, while the NRI indexes were 32 (Pvalue ¼ 0.106), 30 (P-value ¼ 0.114) and 21% (P-value ¼ 0.261) (Figure 1) . Calibration was satisfying: P-value for HosmerLemeshow w 2 test reached 0.303, 0.351 and 0.583 for the models including PWV, PP and number of CFP, respectively (Table 3) .
After adjustment for FRS, IMT was no longer significantly associated with cardiovascular mortality (Table 3) .
DISCUSSION
Carotid-femoral PWV, PP and number of carotid or femoral atherosclerotic plaques were significantly and independently associated with cardiovascular death in this study, and they improved the identification of individuals at high cardiovascular risk among people from the general population. Adding vascular markers to FRS in prediction models inevitably increased overestimation of risk in patients with low cardiovascular risk, which actually corresponds to a decrease in specificity. The observation of an IDI significantly above 0, means that the decreased specificity is counterbalanced by an increased sensitivity, the gain in sensitivity being greater than the loss in specificity. In other words, adding new markers improved sensitivity without excessively penalising specificity.
Many studies have shown that vascular markers are independent determinants of cardiovascular risk. However, to our knowledge, only few have evaluated the additional value of these markers in cardiovascular risk stratification in apparently healthy subjects. We were unable to find data on the use of PP in cardiovascular risk stratification although this marker is known to be an independent determinant of cardiovascular risk. [10] [11] [12] On the other hand, Mattace et al. 13 have shown that adding PWVto traditional cardiovascular risk factors in an algorithm predicting the occurrence of cardiovascular diseases, significantly improves the C-statistic of the prediction model. In a paper from Sehestedt et al., 15 NRI was equal to 9% when carotid plaques and PWVwere used as predictors together with the European SCORE algorithm. 
Improved prediction of cardiovascular death E Bé rard et al
Nambi et al. 14 have shown that carotid IMT or the presence of carotid plaques improves significantly discrimination in the prediction of coronary heart disease compared with traditional cardiovascular risk factors. In that paper, the estimated NRI were 7 and 8% for IMT and carotid plaques, respectively. Finally, in the very recent papers from Baldassarre, 16 Yeboah, 17 Ruitjer 18 and Kavousi et al., 19 based either on US or North-European samples from the general population, carotid IMT improved prediction of cardiovascular risk compared with Framingham risk factors (NRI ¼ 4.8%, 6.0%, 0.8%, 1.6%, respectively). Hazard ratios (HR) for cardiovascular mortality and 95% CI were assessed using a proportional subdistribution hazard model, which is an extension of the Cox model to the situation of competing risks.
b Integrated discrimination improvement. high, intermediate and low risks were defined as 10-year risk of coronary heart disease 420%, 10-20% and o10%, respectively. 31 Using FRS with a vascular marker: high, intermediate and low risks were defined as 14-year risk of cardiovascular mortality 45%, 1-5% and o1%, 31 respectively. NRI is assessed for subjects without missing data for vascular markers (respectively N ¼ 974, N ¼ 1132 and N ¼ 981 for PWV, PP and number of CFP). CFP, carotid or femoral plaque; FRS, Framingham Risk Score; IMT, common carotid intima-media thickness; PP, pulse pressure; PWV, carotid-femoral pulse wave velocity.
In our study, carotid IMT was not significantly associated with cardiovascular risk after adjustment for FRS. This discrepancy compared with previous published results might be explained by the fact that our study sample, recruited from the general population of South-western France, probably exhibited a cardiovascular risk and IMT values lower than those observed in previous published papers. Indeed, less than 1% of the sample presented with IMT above 0.9 mm, which is the threshold proposed by the European guidelines to define an increased cardiovascular risk. 33 Given that almost all participants had a normal IMT, studying the predictive value of an elevated IMT was difficult in our sample. It is likely that the predictive power of IMT in predicting cardiovascular events is greater among intermediate or high risk subjects than among subjects at lower risk.
In the present work, we chose to study the value of various vascular markers in different prediction models, in order to assess, in a cost-effective way, the best marker for improving the screening of apparently healthy subjects. When all vascular markers (PWV, PP and number of CFP) were included in a single model together with FRS, the number of CFP did not remain significantly associated with cardiovascular mortality (data not shown), thus suggesting that the more powerful predictive markers were PWV and PP. These two markers are measured with simple, noninvasive procedures that do not need the use of ultrasonography and are easy to be included in patients' clinical examination, in preventive cardiovascular units, but also in general medical practice. Adding these markers to already available risk prediction algorithms might be important for developing cost-effective disease prevention.
In this paper, we chose to present results regarding the improvement of cardiovascular risk stratification compared with the FRS, because this algorithm is the most widely used for risk prediction worldwide. Another algorithm frequently used is the SCORE equation, which is recommended by the European Society of Cardiology for risk assessment in European countries. 31 A main drawback of the SCORE equation lies in the fact it is not adapted to diabetic subjects. However, replacing the FRS by the SCORE equation in our analyses, led to results very close to those we present in this paper (data shown in Supplementary Appendix).
This study has several limitations that must be addressed. First, our results, although highly significant, are based on small numbers of cardiovascular deaths (N ¼ 12). Consequently, data from larger cohorts are still needed. Second, our analysis is based on a low cardiovascular risk population (free-living people from South-Western France), making hazardous the generalisation of the results to higher risk populations. One can anticipate a stronger impact of vascular markers among higher risk populations, and consequently a greater contribution of these markers to the discrimination of subjects who will from those who will not develop a cardiovascular event in the coming years. Moreover, the relatively high NRI we observed in our study may be related to the fact that the Framingham equation is less accurate to predict cardiovascular risk among French people, than in other populations with a risk close to the risk exhibited by the Framingham population. Finally, our study analysed data collected from death certificates, whose quality is heterogeneous, depending on the practitioner who fills in the certificate. To minimise potential biases, all causes of death recorded on the certificates (main and associated causes of death) were evaluated by a committee of four medical doctors to reach a consensus on the cause considered to be the most likely.
In conclusion, vascular markers may bring valuable additional information to improve the identification of subjects at high cardiovascular risk in the general population. These markers are simply measured in routine, and thus are particularly of interest for developing cost-effective cardiovascular risk prevention. Studies conducted in greater samples and in populations at higher baseline cardiovascular risk are still needed to confirm these results.
What is known about topic
The assessment of global cardiovascular risk is uniformly recommended as a decision-support for therapeutic management aimed at preventing cardiovascular diseases in primary prevention. The American Heart Association and the European Society of Cardiology state that additional risk markers could improve estimation of cardiovascular risk currently based on traditional risk factors. Vascular markers of subclinical atherosclerosis are known to be independent determinants of cardiovascular risk but only few studies have previously investigated the additional value of vascular markers in improving the prediction and stratification of cardiovascular risk in apparently healthy subjects.
What this study adds PWV, PP and number of CFPs are independent determinants of cardiovascular mortality in apparently healthy subjects and improve risk prediction as compared with FRS. These markers are simply measured parameters that may be of interest for developing cost-effective cardiovascular risk prevention.
